Synonyms:GSK429286A, 864082-47-3, RHO-15, N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide, GSK 429286, N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide, C21H16F4N4O2, N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)-phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide, N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyridine-3-carboxamide, dihydropyridone indazole, N-(6-FLUORO-1H-INDAZOL-5-YL)-2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXAMIDE, CHEMBL375312, GTPL9356, SCHEMBL2801740, BDBM14055, CHEBI:91332, dihydropyridone indazole amide 15, DTXSID70463946, BCPP000217, HMS3244C07, HMS3244C08, HMS3244D07, HMS3265C03, HMS3265C04, HMS3265D03, HMS3265D04, HMS3654N12, HMS3750C21, AMY39943, BCP01975, EX-A1119, GSK-429286A, GSK 429286 A, HB2290, MFCD16618404, s1474, AKOS024457773, BCP9000743, CCG-269030, CS-0095, GSK-429286, compound 15 [PMID: 17201405], NCGC00346096-02, NCGC00346096-10, 4-[4-(TRIFLUOROMETHYL)PHENYL]-N-(6-FLUORO-1H-INDAZOL-5-YL)-2-METHYL-6-OXO-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXAMIDE, AC-32842, AS-16226, HY-11000, FT-0735355, GSK 429286A;GSK-429286A, SW219547-1, J3.573.349C, F15260, J-523140, BRD-A10523515-001-01-2, Q27163215, 4-[4-(Trifluoromethyl)phenyl]-N-(6- Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tet rahydro-3-pyridinecarboxamide, N-(6-Fluoro-1h-ndazol-5-yl)-2-methyl-6-Oxo-4-(4-(trfluoromethyl)phenyl)-1,4,5,6-tetrahydropyrdne-3-carboxamde
Id:11373846
Description:nan